Please enable JavaScript to continue using this application.

Compare $MGTX vs $TRAX | Chartloom

Compare

$MGTX vs $TRAX

MeiraGTx Holdings PLC · First Tracks Biotherapeutics Inc

MGTX

MeiraGTx Holdings PLC

TRAX

First Tracks Biotherapeutics Inc

Compare $MGTX vs $TRAX

Comparing MeiraGTx Holdings PLC and First Tracks Biotherapeutics Inc

MGTXMeiraGTx Holdings PLC

TRAXFirst Tracks Biotherapeutics Inc

MGTXMeiraGTx Holdings PLC

Market cap

$990M

P/E (TTM)

12.70x

Forward P/E (NTM)

—

Forward P/S (NTM)

27.71x

Rev growth (TTM)

948.3%

YTD performance

36.9%

52W performance

29.4%

FCF yield

1.1%

TRAXFirst Tracks Biotherapeutics Inc

Market cap

$1.11B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

67.6%

52W performance

67.6%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MGTX

TRAX

Detailed metrics comparison

MGTX

MeiraGTx Holdings PLC

TRAX

First Tracks Biotherapeutics Inc

Market Cap

MGTX$990M

TRAX$1.11B

Enterprise Value

MGTX$947M

TRAX$943M

Price

MGTX$10.69

TRAX$31.85

P/E Ratio

MGTX12.70x

TRAXN/A

P/S Ratio

MGTX2.49x

TRAX0.00x

EV/Sales

MGTX2.38x

TRAX0.00x

EV/EBITDA

MGTX4.63x

TRAX0.00x

P/B Ratio

MGTX4.81x

TRAX7.04x

P/FCF Ratio

MGTX94.58x

TRAXN/A

EV/FCF

MGTX90.47x

TRAX0.00x

PEG Ratio

MGTXN/A

TRAXN/A

Forward P/E (NTM)

MGTXN/A

TRAXN/A

Forward P/S (NTM)

MGTX27.71x

TRAXN/A

Revenue (TTM)

MGTX$398M

TRAX$0

Revenue Growth (YoY)

MGTX948.3%

TRAXN/A

Forward Rev Growth

MGTX-75.7%

TRAX0.0%

Gross Margin (TTM)

MGTX97.9%

TRAX0.0%

Operating Margin (TTM)

MGTX46.3%

TRAX0.0%

EBITDA Margin (TTM)

MGTX49.3%

TRAX0.0%

Net Margin (TTM)

MGTX19.9%

TRAX0.0%

FCF Margin (TTM)

MGTX2.6%

TRAXN/A

Net Income (TTM)

MGTX$79M

TRAX$-84M

FCF (TTM)

MGTX$10M

TRAX$0

EPS (TTM)

MGTX$0.84

TRAX-$2.40

ROE (TTM)

MGTX74.6%

TRAX0.0%

ROA (TTM)

MGTX29.4%

TRAX0.0%

ROIC (TTM)

MGTX50.9%

TRAX0.0%

Cash

MGTX$143M

TRAX$168M

Debt

MGTX$100M

TRAX$0

Net Cash/Debt

MGTX$43M

TRAX$168M

Current Ratio (TTM)

MGTX3.76x

TRAX14.28x

Quick Ratio (TTM)

MGTX3.69x

TRAX14.08x

Debt/Equity (TTM)

MGTX0.46x

TRAX0.00x

Debt/Assets (TTM)

MGTX0.0%

TRAX0.0%

Interest Coverage (TTM)

MGTXN/A

TRAXN/A

Net Debt/EBITDA (TTM)

MGTX0.00x

TRAX0.00x

Beta

MGTX1.05

TRAX1.60

52W Performance

MGTX29.4%

TRAX67.6%

YTD Performance

MGTX36.9%

TRAX67.6%

% from 52W High

MGTX-30.4%

TRAX-36.2%

% from 52W Low

MGTX61.5%

TRAX116.4%

Asset Turnover (TTM)

MGTX1.48x

TRAX0.00x

FCF Yield (TTM)

MGTX1.1%

TRAX0.0%

Earnings Yield (TTM)

MGTX8.0%

TRAX-7.5%

Dividend Yield (TTM)

MGTXN/A

TRAXN/A

Rule of 40

MGTX951.0

TRAX0.0

EV/GP/RG

MGTXN/A

TRAXN/A

Ticker research

View MGTX research View TRAX research

Metric	MGTX MeiraGTx Holdings PLC	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$990M	$1.11B
Enterprise Value	$947M	$943M
Price	$10.69	$31.85
P/E Ratio	12.70x	N/A
P/S Ratio	2.49x	0.00x
EV/Sales	2.38x	0.00x
EV/EBITDA	4.63x	0.00x
P/B Ratio	4.81x	7.04x
P/FCF Ratio	94.58x	N/A
EV/FCF	90.47x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	27.71x	N/A
Revenue & Growth
Revenue (TTM)	$398M	$0
Revenue Growth (YoY)	948.3%	N/A
Forward Rev Growth	-75.7%	0.0%
Profitability
Gross Margin (TTM)	97.9%	0.0%
Operating Margin (TTM)	46.3%	0.0%
EBITDA Margin (TTM)	49.3%	0.0%
Net Margin (TTM)	19.9%	0.0%
FCF Margin (TTM)	2.6%	N/A
Net Income (TTM)	$79M	$-84M
FCF (TTM)	$10M	$0
EPS (TTM)	$0.84	-$2.40
ROE (TTM)	74.6%	0.0%
ROA (TTM)	29.4%	0.0%
ROIC (TTM)	50.9%	0.0%
Financial Health
Cash	$143M	$168M
Debt	$100M	$0
Net Cash/Debt	$43M	$168M
Current Ratio (TTM)	3.76x	14.28x
Quick Ratio (TTM)	3.69x	14.08x
Debt/Equity (TTM)	0.46x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.05	1.60
52W Performance	29.4%	67.6%
YTD Performance	36.9%	67.6%
% from 52W High	-30.4%	-36.2%
% from 52W Low	61.5%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	1.48x	0.00x
FCF Yield (TTM)	1.1%	0.0%
Earnings Yield (TTM)	8.0%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	951.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MGTX research	View TRAX research

Valuation

P/E Ratio

MGTX

12.70x

P/S Ratio

TRAX

0.00x

MGTX

2.49x

EV/FCF

TRAX

0.00x

MGTX

90.47x

Growth & revenue

Revenue Growth TTM

MGTX

948.3%

Forward Revenue Growth

TRAX

0.0%

MGTX

-75.7%

Profitability & performance

Gross Margin

MGTX

97.9%

TRAX

0.0%

ROE

MGTX

74.6%

TRAX

0.0%

FCF Yield %

MGTX

1.1%

TRAX

0.0%

52-Week Performance

TRAX

67.6%

MGTX

29.4%

Detailed metrics comparison

MGTX

MeiraGTx Holdings PLC

TRAX

First Tracks Biotherapeutics Inc

Market Cap

MGTX$990M

TRAX$1.11B

Enterprise Value

MGTX$947M

TRAX$943M

Price

MGTX$10.69

TRAX$31.85

P/E Ratio

MGTX12.70x

TRAXN/A

P/S Ratio

MGTX2.49x

TRAX0.00x

EV/Sales

MGTX2.38x

TRAX0.00x

EV/EBITDA

MGTX4.63x

TRAX0.00x

P/B Ratio

MGTX4.81x

TRAX7.04x

P/FCF Ratio

MGTX94.58x

TRAXN/A

EV/FCF

MGTX90.47x

TRAX0.00x

PEG Ratio

MGTXN/A

TRAXN/A

Forward P/E (NTM)

MGTXN/A

TRAXN/A

Forward P/S (NTM)

MGTX27.71x

TRAXN/A

Revenue (TTM)

MGTX$398M

TRAX$0

Revenue Growth (YoY)

MGTX948.3%

TRAXN/A

Forward Rev Growth

MGTX-75.7%

TRAX0.0%

Gross Margin (TTM)

MGTX97.9%

TRAX0.0%

Operating Margin (TTM)

MGTX46.3%

TRAX0.0%

EBITDA Margin (TTM)

MGTX49.3%

TRAX0.0%

Net Margin (TTM)

MGTX19.9%

TRAX0.0%

FCF Margin (TTM)

MGTX2.6%

TRAXN/A

Net Income (TTM)

MGTX$79M

TRAX$-84M

FCF (TTM)

MGTX$10M

TRAX$0

EPS (TTM)

MGTX$0.84

TRAX-$2.40

ROE (TTM)

MGTX74.6%

TRAX0.0%

ROA (TTM)

MGTX29.4%

TRAX0.0%

ROIC (TTM)

MGTX50.9%

TRAX0.0%

Cash

MGTX$143M

TRAX$168M

Debt

MGTX$100M

TRAX$0

Net Cash/Debt

MGTX$43M

TRAX$168M

Current Ratio (TTM)

MGTX3.76x

TRAX14.28x

Quick Ratio (TTM)

MGTX3.69x

TRAX14.08x

Debt/Equity (TTM)

MGTX0.46x

TRAX0.00x

Debt/Assets (TTM)

MGTX0.0%

TRAX0.0%

Interest Coverage (TTM)

MGTXN/A

TRAXN/A

Net Debt/EBITDA (TTM)

MGTX0.00x

TRAX0.00x

Beta

MGTX1.05

TRAX1.60

52W Performance

MGTX29.4%

TRAX67.6%

YTD Performance

MGTX36.9%

TRAX67.6%

% from 52W High

MGTX-30.4%

TRAX-36.2%

% from 52W Low

MGTX61.5%

TRAX116.4%

Asset Turnover (TTM)

MGTX1.48x

TRAX0.00x

FCF Yield (TTM)

MGTX1.1%

TRAX0.0%

Earnings Yield (TTM)

MGTX8.0%

TRAX-7.5%

Dividend Yield (TTM)

MGTXN/A

TRAXN/A

Rule of 40

MGTX951.0

TRAX0.0

EV/GP/RG

MGTXN/A

TRAXN/A

Ticker research

View MGTX research View TRAX research

Metric	MGTX MeiraGTx Holdings PLC	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$990M	$1.11B
Enterprise Value	$947M	$943M
Price	$10.69	$31.85
P/E Ratio	12.70x	N/A
P/S Ratio	2.49x	0.00x
EV/Sales	2.38x	0.00x
EV/EBITDA	4.63x	0.00x
P/B Ratio	4.81x	7.04x
P/FCF Ratio	94.58x	N/A
EV/FCF	90.47x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	27.71x	N/A
Revenue & Growth
Revenue (TTM)	$398M	$0
Revenue Growth (YoY)	948.3%	N/A
Forward Rev Growth	-75.7%	0.0%
Profitability
Gross Margin (TTM)	97.9%	0.0%
Operating Margin (TTM)	46.3%	0.0%
EBITDA Margin (TTM)	49.3%	0.0%
Net Margin (TTM)	19.9%	0.0%
FCF Margin (TTM)	2.6%	N/A
Net Income (TTM)	$79M	$-84M
FCF (TTM)	$10M	$0
EPS (TTM)	$0.84	-$2.40
ROE (TTM)	74.6%	0.0%
ROA (TTM)	29.4%	0.0%
ROIC (TTM)	50.9%	0.0%
Financial Health
Cash	$143M	$168M
Debt	$100M	$0
Net Cash/Debt	$43M	$168M
Current Ratio (TTM)	3.76x	14.28x
Quick Ratio (TTM)	3.69x	14.08x
Debt/Equity (TTM)	0.46x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.05	1.60
52W Performance	29.4%	67.6%
YTD Performance	36.9%	67.6%
% from 52W High	-30.4%	-36.2%
% from 52W Low	61.5%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	1.48x	0.00x
FCF Yield (TTM)	1.1%	0.0%
Earnings Yield (TTM)	8.0%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	951.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MGTX research	View TRAX research